Glucagon (2021-09-25)
- Starting date:
- September 25, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-76509
Last updated:
2021-09-27
Summary
-
Product:
Glucagon
Reason
Eli Lilly is recalling lot D239382A to the retail level because of a product complaint reporting that the vial of Glucagon was in liquid form instead of the powder
Depth of distribution
Retailers
Affected products
Glucagon
DIN, NPN, DIN-HIM
DIN 02243297
Dosage form
Powder for solution, kit
Strength
Glucagon (Recombinant DNA Origin) 1mg/vial
Lot or serial number
D239382A
Companies
- Recalling Firm
-
Eli Lilly Canada Inc.
130 King Street West, Exchange Tower, Suite 900
Toronto
M5X 1B1
Ontario
CANADA
- Marketing Authorization Holder
-
Eli Lilly Canada Inc.
130 King Street West, Exchange Tower, Suite 900
Toronto
M5X 1B1
Ontario
CANADA